Skip to main content
Canadian Urological Association Journal logoLink to Canadian Urological Association Journal
. 2019 Jun 17;14(1):E6–E12. doi: 10.5489/cuaj.5837

The burden of urological disease in Zomba, Malawi: A needs assessment in a sub-Saharan tertiary care center

Tristan Juvet 1,, James R Hayes 2, Sarah Ferrara 1, Duncan Goche 3, Robert D Macmillan 4, Rajiv K Singal 5
PMCID: PMC6955180  PMID: 31658013

Abstract

Introduction

A large part of the developing world continues to lack access to surgical care. Urology remains one of the least represented surgical subspecialties in global health. To begin understanding the burden of urological illness in sub-Saharan Africa, we sought to characterize all patients presenting to a tertiary care hospital in Malawi with a urological diagnosis or related complaint in the past year.

Methods

Retrospective review of the surgical clinic and surgical theater record books at Zomba Central Hospital (ZCH) was performed over a one-year time span. Patients presenting with urological diagnoses or undergoing a urological procedure under local or general anesthetic in the operating theater were identified and entered into a database.

Results

We reviewed 440 clinical patients. The most common clinical presentations were for urinary retention (34.7%) and lower urinary tract symptoms (15.5%). A total of 182 surgical cases were reviewed. The most common diagnoses for surgical patients were urethral stricture disease (22%), bladder masses (17%), and benign prostatic hyperplasia (BPH) symptoms (14.8%). Urethral stricture-related procedures, including direct visual internal urethrotomy and urethral dilatation, were the most common (14.2% and 7.7%, respectively). BPH-related procedures, including simple prostatectomy and transurethral resection of the prostate were the second most common (6.7% and 8.2%, respectively).

Conclusions

Urethral stricture disease, BPH, and urinary retention represent the clinical diagnoses with the highest burden of visits. Despite these numbers, few definitive procedures are performed annually. Further focus on urological training in sub-Saharan Africa should focus on these conditions and their surgical management.

Introduction

A large part of the developing world continues to lack access to surgical care. This situation is accentuated in sub-Saharan Africa. Over the past decades, surgical care has been recognized as an important aspect of global health, benefitting from increased funding and a higher frequency of international missions.1 Despite these advances, urology remains one of the least represented surgical subspecialties in global health, with expenditures well below most other fields.2 Global surgery missions are seldom focused on urological care alone.

The American Urology Association (AUA) has partnered with International Volunteers in Urology (IVUmed), one of the few urology-focused non-governmental organizations, and certainly the largest. This partnership provides funding for volunteer missions incorporating both American and Canadian urologists, resident scholarships, and local training programs. The Canadian Urological Association (CUA) provides regular scholarship programs to provide training for urologists practicing in developing countries. The European Association of Urology (EAU) supports various African urology programs through joint meetings and courses.

In 2002, a charter of “urologic rights” was drafted by Dr. Neville Harrison. This outlined the basic treatments to which patients across the world should have access. This list included treatment of urinary retention, hematuria, urethral stricture disease, urethral trauma, vesicovaginal fistula, penile carcinoma, and access to male circumcision. The most common illnesses thought to be encountered by practicing urologists in sub-Saharan Africa include benign prostatic hyperplasia (BPH), urethral stricture disease, prostate cancer, bladder cancer, and urethral/ureteric trauma.3

Untreated urological conditions represent a major burden on patients in the developing word. Previous studies have found that urological diseases were responsible for over 25 million disability-adjusted life years worldwide, with the highest overall rates in sub-Saharan Africa.4 While there is minimal data available on urological surgical rates, surgical volumes in general are known to be lowest in the developing world. In a review of worldwide surgical volumes, it was noted that the poorest third of the world’s population received only 3.5% of worldwide surgical operations.5 Studies from Sierra Leone have estimated that a quarter of the previous year’s deaths among regular households could have been prevented with timely surgical management.6

Further compounding these issues is the lack of trained staff and equipment. Most sub-Saharan countries have access to only a handful of urologists. The most populous country in Africa, Nigeria, has one urologist per 3.2 million people. Training programs are uncommon and funding for both education and access to care is limited.7 There are approximately 145 000 physicians in sub-Saharan Africa for a population over one billion.8 In addition, urology remains a specialty where a large amount of specialized equipment requiring regular maintenance is needed.

Zomba is Malawi’s fourth largest city, with a regional population of over 600 000. Zomba Central Hospital (ZCH) is one of the four national tertiary care centers, with a referral population of approximately four million.9 ZCH is unique in Malawi, as it is one of the only sites offering urological procedures. Additional surgical services at the site include general surgery, orthopedic surgery, and obstetrics and gynecology.

Care at ZCH, as in many sub-Saharan clinics and hospitals, is mainly provided by clinical officers: non-physicians who have undergone approximately two to three years of generalist post-secondary training. Malawian clinical officers undergo an additional one-year internship following their training. Along with nurse practitioners, physician’s assistants, and similar professions, they are categorized as non-physician clinicians (NPCs). In Malawi, there are over twenty times more NPCs than there are physicians.10 With appropriate training and supervision, surgical NPCs were found to have complication rates similar to surgeons at ZCH.9

Prevalence studies on urological diseases in this region of the world remain limited in quantity. This, in turn, may limit the resources provided to particular areas in terms of equipment, funding, and appropriately trained staff. In order to begin understanding the burden of urological illness in this community, we sought to characterize all patients presenting to the surgical clinic with a urological diagnosis or related complaint in the past year.

Methods

Retrospective review of the surgical clinic and surgical theater record books at ZCH was performed for a one-year time span from March 2017 to March 2018 and manually transcribed into an electronic database. This review was performed as part of an expanding global surgery initiative within the Division of Urology at the University of Toronto.

We examined the clinical records of all patients presenting to the surgical clinic with a urological diagnosis or chief complaint. Clinical visit diagnoses were based on presenting symptoms or known previous medical history, as assessed by the clinical staff. Similarly, for surgical records, we extracted relevant data for all patients undergoing urological procedures. This included any procedure performed by the urology clinical officer or visiting urologists under local or general anesthetic in the operating room.

As there is no computer system within the hospital, the information contained in these logbooks was manually entered. Clinical logbook data was entered by both the administrative staff and clinical officers. Surgical logbooks were filled by clinical officers and surgeons, both local and visiting.

Information was taken from the patient’s “Health Passport,” a small, handwritten booklet owned by the patient containing all relevant medical information as documented by medical personnel. Data obtained from clinical records included age, gender, diagnosis, and month of service. Data from surgical logs included age, gender, diagnosis, procedure, and anesthetic (local, spinal, or general).

Most operating room urological procedures were performed by the trained urology clinical officer. In certain cases, assistance was sought from the single attending general surgeon present at the hospital. In other circumstances, visiting international surgeons from Canada or Germany assisted with procedures. Urological operative cases were included based on procedure and diagnosis, and the completion of the procedure by the general surgery team did not exclude it from this study.

Results

Review and analysis of the surgical clinic record revealed a total of 440 patients visited the surgical clinic for a urology-specific complaint over the one-year time frame (Table 1). Most (425, 96.59%) patients were male. The most common complaints were related to urinary retention (34.77%), lower urinary tract symptoms (LUTS) (15.45%), hydrocele (10.23%), urethral stricture (8.86%), and bladder mass (6.82%). It should be noted that retention-related visits included both acute and chronic presentations. Additional common diagnoses included orchitis/scrotal pain (6.14%) and phimosis (4.32%).

Table 1.

Clinic visits by diagnosis

Diagnosis n (%) Average age
 Retention 153 (34.77%) 71.1
 Lower urinary tract symptoms 68 (15.45%) 70.16
 Hydrocele 45 (10.23%) 43.42
 Stricture 39 (8.86%) 46.67
 Bladder mass 30 (6.82%) 51.52
 Orchitis 27 (6.14%) 43.36
 Phimosis 19 (4.32%) 17.24
 Prostate cancer 12 (2.73%) 66.73
 Prostatitis 10 (2.27%) 64.22
 Paraphimosis 8 (1.82%) 18.25
 Scrotal mass 5 (1.14%) 39.2
 Penile cancer 3 (0.68%) 50
 Hydronephrosis 2 (0.45%) 54.5
 Hypospadias 2 (0.45%) 18
 Incontinence 2 (0.45%) 49.5
 Scrotal abscess 2 (0.45%) 50
 Scrotal swelling 2 (0.45%) 31
 Bladder stone 1 (0.23%) 72
 Circumcision 1 (0.23%) 24
 Imperforate vagina 1 (0.23%) 70
 Kidney abscess 1 (0.23%) 48
 Kidney stone 1 (0.23%) 35
 Meatal stenosis 1 (0.23%) 55
 Penile ulcer 1 (0.23%) 67
 Postop scrotal hematoma 1 (0.23%) 74
 Scrotal fistula 1 (0.23%) 46
 Undescended testicles 1 (0.23%) 3
 Urethral trauma 1 (0.23%) 41
 Total 440 (100.00%) 57.6
Clinic visits by gender
 Male: 425 patients (96.59%)
 Female: 15 patients (3.41%)

The median age of patients attending the surgical clinic with a urological complaint was 48 years. Men presenting to the clinic with urinary retention were older and had a mean age of 71.1 years. Patients presenting with urethral stricture were younger and, on average, were 46.7 years old. The youngest patients were those presenting with phimosis-related complaints, with an average age of 17 years. One three-year-old patient was seen for an undescended testicle.

Review of surgical records showed 182 urological cases performed over the one-year time frame (Table 2). Median age of surgical patients was 50 years. The most common diagnosis for patients undergoing surgery was urethral stricture disease (21.98%), followed by bladder mass (17.03%), BPH (14.84%), hydrocele (9.34%), and prostate cancer (5.49%). Of the recorded cases, the most common procedure performed was cystoscopy (30 cases, 16.48%), followed by direct visual internal urethrotomy (DVIU) (26 cases, 14.29%), hydrocelectomy (17 cases, 9.34%), simple prostatectomy (15, 8.24%), urethral dilatations (14 cases, 7.69%), and transurethral resection of the prostate (TURP) (12 cases, 6.59%) (Table 3).

Table 2.

Most responsible diagnosis for patients undergoing urological surgery

Diagnosis n (%)
 Stricture 40 (21.98%)
 Bladder mass 31 (17.03%)
 Benign prostatic hyperplasia 27 (14.84%)
 Hydrocele 17 (9.34%)
 Prostate cancer 10 (5.49%)
 Necrotizing fasciitis 7 (3.85%)
 Testicular torsion 6 (3.30%)
 Penile cancer 5 (2.75%)
 Bladder stone 4 (2.20%)
 Cryptorchidism 4 (2.20%)
 Bladder neck stenosis 3 (1.65%)
 Hypospadias 3 (1.65%)
 Meatal stenosis 3 (1.65%)
 Phimosis 2 (1.10%)
 Priapism 2 (1.10%)
 Testicular lesion 2 (1.10%)
 Ambiguous genitalia 1 (0.55%)
 Bladder ulcers 1 (0.55%)
 Gross hematuria 1 (0.55%)
 Hydronephrosis 1 (0.55%)
 Kidney stone 1 (0.55%)
 Paraphimosis 1 (0.55%)
 Penile trauma 1 (0.55%)
 Perforated bladder 1 (0.55%)
 Prostatic abscess 1 (0.55%)
 Renal tumour 1 (0.55%)
 Scrotal abscess 1 (0.55%)
 Scrotal hematoma 1 (0.55%)
 Urethral fistula 1 (0.55%)
 Urethral stone 1 (0.55%)
 Urethral trauma 1 (0.55%)
 UTI 1 (0.55%)
 Total 182 (100.00%)

Table 3.

Procedures performed for patients having urological surgery

Procedure n (%) Surgical assist
 Cystoscopy 30 (16.48%)
 VIU 26 (14.29%) 8 cases performed with urologists from Canada
 Hydrocelectomy 17 (9.34%)
 Simple prostatectomy 15 (8.24%)
 Urethral dilatation 14 (7.69%)
 TURP 12 (6.59%) 11 cases performed with urologist from Germany/Canada
 Debridement for Fournier’s 10 (5.49%)
 Orchiectomy for trauma/cryptorchidism 10 (5.49%)
 Bilateral orchiectomy for prostate cancer 9 (4.95%)
 Cystectomy with ileal conduit 4 (2.20%) 3 cases performed in conjunction with ZCH general surgeon
 Open cystolithotomy 4 (2.20%)
 TURBT 4 (2.20%) Visiting urologists from Canada
 Circumcision 3 (1.65%)
 Hypospadias repair 3 (1.65%) Visiting urologist from Germany
 TURBN 3 (1.65%)
 Orchidopexy for undescended testis 2 (1.10%) Visiting urologists from Germany/Canada
 Partial cystectomy 2 (1.10%)
 Shunt for priapism 2 (1.10%)
 Suprapubic catheter 2 (1.10%)
 Scrotal hematoma evacuation 1 (0.55%)
 Open bladder repair for perforation 1 (0.55%)
 Partial penectomy 1 (0.55%) Visiting urologist from Germany
 Percutaneous nephrostomy 1 (0.55%)
 Primary urethral realignment 1 (0.55%)
 Paraphimosis reduction 1 (0.55%)
 Open radical nephrectomy 1 (0.55%) Performed by ZCH general surgeon
 Renal stone removal 1 (0.55%)
 Total penectomy 1 (0.55%) Visiting urologist from Germany
 Urethrocutaneostomy 1 (0.55%)
 Total 182 (100.00%)

TURP: transurethral resection of the prostate; TURBT: transurethral resection of the bladder tumor; TURBN: transurethral resection of the bladder neck; VIU: visual internal urethrotomy.

Of note, only a single urethrocutaneostomy was performed over the course of this year for penile trauma. No urethroplasties or urethral reconstructive surgeries were performed for stricture disease. Two penectomies were performed in conjunction with a visiting surgeon from Germany. Of the four radical cystectomies performed, three were with assistance from the attending Malawian general surgeon. Diversion techniques were not recorded. A single radical nephrectomy was also performed by the general surgeon. Surgical assists are summarized in Table 3.

Spinal anesthesia was used in 104 (68.7%) cases and was the preferred option by the anesthetists and clinical officers at ZCH. Larger and longer procedures were performed under a general anesthetic (29 cases, 15.93%). Shorter, less invasive procedures, such as cystoscopy and urethral dilation, were mainly performed with local anesthetic alone (28 cases, 15.38%) (Table 4).

Table 4.

Anesthesia selection for patients undergoing urological surgery

Procedure n (%)
 Spinal 125 (68.68%)
 GA 29 (15.93%)
 Local 28 (15.38%)
 Total 182 (100.00%)

GA: general anesthetic.

Discussion

This study shows a diverse presentation of urological conditions, both clinically and surgically, in a large urban center with no formally trained practicing urologist. Urinary retention-related complaints made up over one-third of our clinic visits yet represented only 27 surgical cases (14.83%). Anecdotally, an estimated 2000 regional patients live with indwelling catheters. Adding to the issue, catheters are often placed in rural clinics without a clear diagnosis or followup plan.

Furthermore, access to equipment and training for endoscopic management of BPH remains highly challenging. Open simple prostatectomies remain commonly performed in Malawi by both clinical officers and general surgeons, however, more urgent surgical procedures are often prioritized. Most TURPs performed at ZCH were in conjunction with visiting international surgeons due to lack of training and experience with the resectoscope.

Household survey data from a study in Sierra Leone identified a prevalence of 1.99% for men with urinary retention and 2.18% for men with gross hematuria. Over half the men in this study had retention for over a year and approximately 20% reported not being able to work due to this condition. Furthermore, 48% could not afford treatment or surgical care.11 Gross hematuria was not identified as a presenting complaint among our patients, although it may represent a subset of patients presenting with LUTS.

Visits for LUTS hovered around 15% at our site, similar to previous reports showing a prevalence of about 19% in East African men.12 A recent assessment of the prevalence of LUTS in Ugandan men above the age of 55 found rates of 40.5% for moderate symptoms and 20% for severe symptoms as per the International Prostate Symptom Scale.13 Extrapolating this data to encompass sub-Saharan Africa, the authors estimate that over 20 million men suffer from moderate to severe LUTS.

Although the severity of LUTS was not quantified in our review, previous studies from Ghana and Uganda have shown that it is uncommon for men to present with mild to moderate LUTS and surgery is often performed only in cases of retention.14 Among men presenting to a Ugandan urology clinic for LUTS, 82.4% were experiencing moderate to severe LUTS. These patients expressed lower quality of life, increased bother from their symptoms, and experienced daily worry and work interference associated with their symptoms.15 A 2010 review of worldwide LUTS found that over 1.1 billion people worldwide were affected by LUTS in 2008, with Africa expecting the biggest increase in affected individuals over the proceeding decade.16

These numbers highlight a greater need for sustainable surgical management of urinary retention and recalcitrant LUTS. In addition, further measures are needed to promote public awareness and educate our local colleagues that LUTS are amenable to simple and inexpensive medical treatment when a timely diagnosis is made. Ignorance with regards to symptom progression and late presentation currently contribute to presentation with advanced disease, unacceptable morbidity, and the need for surgical intervention.

Cystoscopy aside, DVIUs represented the second most common urological surgical procedure at ZCH and fourth most common clinical visit. Small studies from Cameroon and Nigeria have yielded similar data with regards to average age groups (mean age between 40 and 60 years) and initial treatments consisting primarily of suprapubic diversion and urethral dilatation and/or DVIU. Over half of all strictures were attributed to sexually transmitted infections in these reviews.17,18 Geographical differences in stricture etiology have been studied, with trauma and idiopathic causes being predominant in the developing world.19

Many patients presenting with stricture disease at ZCH are often seen with recurrent or lengthy strictures. These patients would be considered poor candidates for repeated VIU and/or dilatations within our healthcare system and would ideally best be served by urethroplasty. We propose that perineal urethrostomy would be an ideal approach for many of these patients, requiring the least resources and training. Costs for a formal urethroplasty in a similarly sized Nigerian hospital were reported to be $800–1000 USD, well out of the means of most sub-Saharan Africans. Lack of surgical training in this field among local practitioners remains a major barrier to treatment of urethral stricture disease in this region.

Treatment of malignancies in sub-Saharan Africa is uncommon and patients often present late in the course of their disease. Prostate cancer incidence is thought to be rising in many African countries, although the exact number remains difficult to quantify due to lack of proper registries.20 Prostate cancer is thought to be the most common malignancy among men in sub-Saharan Africa and it is often underdiagnosed and/or underreported.21 A review of Nigerian patients with prostate cancer found that over 94% presented with advanced disease. Similarly to our patients, bilateral simple subcapsular orchiectomy was the preferred treatment option.22 Anti-androgens, and access to radiotherapy and chemotherapy are scarcely available and expensive.23 General knowledge surrounding prostate cancer and availability of prostate-specific antigen (PSA) screening have been shown to be lacking in a similar population in a large urban center in Uganda.24

Data on bladder cancer incidence and treatment in Africa remains extremely limited. Epidemiological studies have shown that incidence rates in African men and women remain some of the lowest in the world. Some exceptions were noted, however, with higher rates among Egyptian men and Malawian women.25 While women only represented 10% (18/182) of all surgical cases, 42% (13/31) of all patients undergoing bladder mass surgeries, including transurethral resection of bladder tumor (TURBT), radical cystectomy, or partial cystectomy, were women.

Schistosomiasis is thought to be a leading cause of bladder cancer in Malawi, as it is in most of sub-Saharan Africa, although exact data on prevalence remains unclear.26,27 In a review of biopsies performed in Blantyre, Malawi, about 53% of bladder biopsies were found to contain squamous cell carcinoma and 67.4% of these patients were women.28 At our center, most patients undergoing cystoscopy appeared to have advanced disease and only young, healthy patients were given an opportunity at surgical management of suspected bladder cancer, often without a definitive preoperative diagnosis. Both surgical and non-surgical patients with bladder cancer are often lost to followup

Access to pathology remains a significant problem in sub-Saharan Africa. A survey in 2012 identified only six licensed pathologists within Malawi.29 This represents approximately one pathologist per 2.6 million people, in comparison with the U.S. average of one per 20 000 people. In our center, transportation of the specimen and costs associated with specimen processing were the responsibility of the patient and their families. The average cost of having a specimen analyzed at the nearest university hospital was estimated to be $30 USD, a fee the majority of the population cannot afford. As such, most specimens are disposed of following surgery.

Interestingly, obstetric fistula disease was not a clearly identified diagnosis in our review despite representing a major public health issue in sub-Saharan Africa with up to 130 000 new cases every year.30 Most of the fistula repairs at ZCH are performed by the attending gynecologist, and these are few in number. We suspect that the presence of well-established programs for fistula repair in the cities of Blantyre and Lilongwe lead most patients with this condition to seek treatment at these centers.31

An initial partnership with a Canadian urologist spearheaded the construction of new urology-focused operating rooms and donation of new endoscopic equipment. Visiting Canadian and German urologists were able to perform procedures requiring additional expertise and technical skills beyond those of the clinical associates or the on-site ZCH general surgeon. These procedures focused mostly on use of the resectoscope, pediatric surgery, and penile surgery. While initial Canadian visits were performed under the auspices of a prominent Canadian NGO in Malawi, more recent collaborations have been through the nascent University of Toronto global surgery program.

These visits have provided valuable training to the clinical officers onsite and this has translated into a higher volume of cases, improved surgical technique, and more frequent use of endoscopic surgery at the site, namely DVIUs. While attempts have been made to schedule specialized and complex cases in conjunction with international visits, the lack of adequate medical records and communication means between the hospital and patients makes this challenging. Early coordination with ZCH staff and case selection is a goal of future visits.

Limitations to this study include lack of more detailed diagnoses available from both the clinical and surgical logbooks and lack of additional retrospective data. Data are often entered by nurses or NPCs and patients often have little knowledge of any previous diagnoses when returning to clinic. Patients presenting after-hours or for emergency cases were also not included in the clinical logbooks. Certain diagnoses may not be accurate given the lack of laboratory or diagnostic investigations, such as PSA testing or biopsy. Volume of surgical procedures at ZCH were also often limited by availability of an anesthetist or anesthesia NPC. Although we believe that these findings are relatable to other large sub-Saharan African hospitals, this is yet to be confirmed in similar studies.

Conclusions

The range of cases seen at ZCH is similar to previously reported data in sub-Saharan Africa. The most common presentations are for issues related to urinary retention, urethral stricture disease, and bladder cancer. The most commonly encountered surgical procedures are related to endoscopic management of urethral stricture disease and BPH-related surgery (open simple prostatectomy or TURP). While bladder cancer is frequently encountered, treatment options are limited and patients present late in the course of their disease. Further focus on urological training in sub-Saharan Africa should focus on these conditions and their surgical management and coordination with ongoing public health efforts to reduce the incidence of schistosomiasis.

As our global urology efforts expand, we hope to continue increasing the number of visiting trainees and practicing urologists to provide both teaching and logistical support for urological services at ZCH. A Malawian resident is also undergoing Canadian-funded training in Zambia through the College of Surgeons of East, Central and Southern Africa (COSECSA). At completion of his training in late 2019, he will be joining ZCH as its first fully trained urologist. The goal of our program is to have him establish one of the few urological practices in this region of the world. Identifying and training future residents would have the potential to create an official COSECSA training program in Zomba. Canadian urologists can play a key role in contributing to surgical teaching in Africa and the development of recognized training programs. Additional plans include allocating funds for outreach camps at local district hospitals, improving access to histopathological analysis, and upgrades to the operating rooms and equipment.

Footnotes

Competing interests: Dr. Singal has served on advisory boards for Endoluxe Inc, Hybridyne, and Marion Surgical; has received payment from Marion Surgical; and holds investments in Hybridyne and Marion Surgical. The remaining authors report no competing personal or financial interests related to this work.

This paper has been peer-reviewed.

References

  • 1.Gutnik LA, Dielman J, Dare AJ, et al. Funding flows to global surgery: An analysis of contributions from the USA. Lancet. 2015;385:S51. doi: 10.1016/S0140-6736(15)60846-7. [DOI] [PubMed] [Google Scholar]
  • 2.Gutnik L, Yamey G, Riviello R, et al. Financial contributions to global surgery: An analysis of 160 international charitable organizations. Springerplus. 2016;5:1558. doi: 10.1186/s40064-016-3046-z. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Campain NJ, MacDonagh RP, Mteta KA, et al. Global surgery – How much of the burden is urological? BJU Int. 2015;116:314–6. doi: 10.1111/bju.13170. [DOI] [PubMed] [Google Scholar]
  • 4.Murray CJL, Vos T, Lozano R, et al. Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990–2010: A systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2012;380:2197–223. doi: 10.1016/S0140-6736(12)61689-4. [DOI] [PubMed] [Google Scholar]
  • 5.Weiser TG, Regenbogen SE, Thompson KD, et al. An estimation of the global volume of surgery: A modelling strategy based on available data. Lancet. 2008;372:139–44. doi: 10.1016/S0140-6736(08)60878-8. [DOI] [PubMed] [Google Scholar]
  • 6.Groen RS, Samai M, Stewart KA, et al. Untreated surgical conditions in Sierra Leone: A cluster randomized, cross-sectional, countrywide survey. Lancet. 2012;380:1082–7. doi: 10.1016/S0140-6736(12)61081-2. [DOI] [PubMed] [Google Scholar]
  • 7.Olapade-Olaopa EO, Onawola KA. Challenges for urology in sub-Saharan Africa in 2006. J Men’s Heal Gend. 2006;3:109–16. doi: 10.1016/j.jmhg.2006.01.004. [DOI] [Google Scholar]
  • 8.Mullan F, Frehywot S, Omaswa F, et al. Medical schools in sub-Saharan Africa. Lancet. 2011;377:1113–21. doi: 10.1016/S0140-6736(10)61961-7. [DOI] [PubMed] [Google Scholar]
  • 9.Wilhelm TJ, Thawe IK, Mwatibu B, et al. Efficacy of major general surgery performed by non-physician clinicians at a central hospital in Malawi. Trop Doct. 2011;41:71–5. doi: 10.1258/td.2010.100272. [DOI] [PubMed] [Google Scholar]
  • 10.Mullan F, Frehywot S. Non-physician clinicians in 47 sub-Saharan African countries. Lancet. 2007;370:2158–63. doi: 10.1016/S0140-6736(07)60785-5. [DOI] [PubMed] [Google Scholar]
  • 11.Patel HD, Kamara TB, Kushner AL, et al. Gross hematuria and urinary retention among men from a nationally representative survey in Sierra Leone. Urology. 2014;83:1273–8. doi: 10.1016/j.urology.2014.01.038. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Chokkalingam AP, Yeboah ED, DaMarzo A, et al. Prevalence of BPH and lower urinary tract symptoms in West Africa. Prostate Cancer Prostate Dis. 2012;15:170–6. doi: 10.1038/pcan.2011.43. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Bajunirwe F, Stothers L, Berkowitz J, et al. Prevalence estimates for lower urinary tract symptom severity among men in Uganda and sub-Saharan Africa based on regional prevalence data. Can Urol Assoc J. 2018;12:447–52. doi: 10.5489/cuaj.5105. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Kyei MY, Mensah JE, Morton B, et al. Surgical management of BPH in Ghana: A need to improve access to transurethral resection of the prostate. East Afr Med J. 2012;89:241–5. [PubMed] [Google Scholar]
  • 15.Stothers L, MacNab AJ, Bajunirwe F, et al. Associations between the severity of obstructive lower urinary tract symptoms and care-seeking behavior in rural Africa: A cross-sectional survey from Uganda. PLoS One. 2017;12:1–10. doi: 10.1371/journal.pone.0173631. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Irwin DE, Kopp ZS, Agatep B, et al. Worldwide prevalence estimates of lower urinary tract symptoms, overactive bladder, urinary incontinence and bladder outlet obstruction. BJU Int. 2011;108:1132–9. doi: 10.1111/j.1464-410X.2010.09993.x. [DOI] [PubMed] [Google Scholar]
  • 17.Olajide AO, Olajide FO, Kolawole OA, et al. A retrospective evaluation of challenges in urethral stricture management in a tertiary care center of a poor resource community. Nephrourol Mon. 2013;5:974–7. doi: 10.5812/numonthly.13053. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Ngaroua, Eloundou NJ, Djibrilla Y, et al. Aspects épidémiologiques, cliniques et prise en charge de sténose urétrale chez l’adulte dans un Hôpital de District de Ngaoundéré, Cameroun. Pan Afr Med J. 2017;26:1–6. doi: 10.11604/pamj.2017.26.193.9669. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Stein DM, Thum DJ, Barbagli G, et al. A geographic analysis of male urethral stricture aetiology and location. BJU Int. 2013;112:830–4. doi: 10.1111/j.1464-410X.2012.11600.x. [DOI] [PubMed] [Google Scholar]
  • 20.Adeloye D, David RA, Aderemi AV, et al. An estimate of the incidence of prostate cancer in Africa: A systematic review and meta-analysis. PLoS One. 2016;11:1–18. doi: 10.1371/journal.pone.0153496. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.Rebbeck TR, Devesa SS, Chang B-L, et al. Global patterns of prostate cancer incidence, aggressiveness, and mortality in men of African descent. Prostate Cancer. 2013;2013:1–12. doi: 10.1155/2013/560857. [DOI] [Google Scholar]
  • 22.Badmus TA, Adesunkanmi ARK, Yusuf BM, et al. Burden of prostate cancer in southwestern Nigeria. Urology. 2010;76:412–6. doi: 10.1016/j.urology.2010.03.020. [DOI] [PubMed] [Google Scholar]
  • 23.Kingham TP, Alatise OI, Vanderpuye V, et al. Treatment of cancer in sub-Saharan Africa. Lancet Oncol. 2013;14:e158–67. doi: 10.1016/S1470-2045(12)70472-2. [DOI] [PubMed] [Google Scholar]
  • 24.Nakaandi H, Kirabo M, Semgabo C, et al. Knowledge, attitudes and practices of Ugandan men regarding prostate cancer. Afr J Urol. 2013;19:165–70. doi: 10.1016/j.afju.2013.08.001. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.Babjuk M. Trends in bladder cancer incidence and mortality: Success or disappointment? Eur Urol. 2017;71:109–10. doi: 10.1016/j.eururo.2016.06.040. [DOI] [PubMed] [Google Scholar]
  • 26.Makaula P, Sadalaki JR, Muula AS, et al. Schistosomiasis in Malawi: A systematic review. Parasites Vectors. 2014;7:570. doi: 10.1186/s13071-014-0570-y. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27.Bowa K, Mulele C, Kachimba J, et al. A review of bladder cancer in sub-Saharan Africa: A different disease, with a distinct presentation, assessment, and treatment. Ann Afr Med. 17:99–105. doi: 10.4103/aam.aam_48_17. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28.Mtonga P, Masamba L, Milner D, et al. Biopsy case mix and diagnostic yield at a Malawian central hospital. Malawi Med J. 2013;25:62–4. [PMC free article] [PubMed] [Google Scholar]
  • 29.Adesina A, Chumba D, Nelson AM, et al. Improvement of pathology in sub-Saharan Africa. Lancet Oncol. 2013;14:e152–7. doi: 10.1016/S1470-2045(12)70598-3. [DOI] [PubMed] [Google Scholar]
  • 30.Wall LL. Obstetric vesicovaginal fistula as an international public-health problem. Lancet. 2006;368:1201–9. doi: 10.1016/S0140-6736(06)69476-2. [DOI] [PubMed] [Google Scholar]
  • 31.Drew LB, Wilkinson JP, Nundwe W, et al. Long-term outcomes for women after obstetric fistula repair in Lilongwe, Malawi: A qualitative study. BMC Pregnancy Childbirth. 2016;16:1–12. doi: 10.1186/s12884-015-0755-1. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Canadian Urological Association Journal are provided here courtesy of Canadian Urological Association

RESOURCES